FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104072969> ?p ?o ?g. }

• W2104072969 endingPage "3684" @default.
• W2104072969 startingPage "3678" @default.
• W2104072969 abstract "The TGF-β signaling pathway is crucial in the progression and metastasis of malignancies. We investigated whether the serum TGF-β1 level was related to the outcomes of patients treated with sorafenib for advanced hepatocellular carcinoma (HCC).We selected patients who had received sorafenib-containing regimens as first-line therapy for advanced HCC between 2007 and 2012. Serum TGF-β1 levels were measured and correlated with the treatment outcomes. The expression TGF-β1 and the sensitivity to sorafenib were examined in HCC cell lines.Ninety-one patients were included; 62 (68%) were hepatitis B virus surface antigen (+), and 11 (12%) were anti-hepatitis C virus (+). High (≥ median) pretreatment serum TGF-β1 levels (median 13.7 ng/mL; range, 3.0-41.8) were associated with high α-fetoprotein levels, but not with age, gender, or disease stage. Patients with high pretreatment serum TGF-β1 levels exhibited significantly shorter progression-free survival (median, 2.5 vs. 4.3 months; P = 0.022) and overall survival (median 5.6 vs. 11.6 months; P = 0.029) than did patients with low serum TGF-β1 levels. Compared with pretreatment levels, the serum TGF-β1 levels were significantly increased at disease progression (n = 29, P = 0.010). In preclinical models of HCC, higher TGF-β1 expression levels were associated with poorer sensitivity to sorafenib.High pretreatment serum TGF-β1 levels were associated with poor prognoses, and increased serum TGF-β1 levels were associated with the disease progression of advanced HCC patients. TGF-β pathway may be explored as a therapeutic target for advanced HCC." @default.
• W2104072969 created "2016-06-24" @default.
• W2104072969 creator A5005962077 @default.
• W2104072969 creator A5015972707 @default.
• W2104072969 creator A5017953971 @default.
• W2104072969 creator A5023161976 @default.
• W2104072969 creator A5045902068 @default.
• W2104072969 creator A5073631191 @default.
• W2104072969 date "2015-08-13" @default.
• W2104072969 modified "2023-09-27" @default.
• W2104072969 title "High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib" @default.
• W2104072969 cites W1565561072 @default.
• W2104072969 cites W1965929829 @default.
• W2104072969 cites W1970098795 @default.
• W2104072969 cites W1970329283 @default.
• W2104072969 cites W1971837077 @default.
• W2104072969 cites W1982585264 @default.
• W2104072969 cites W1985157285 @default.
• W2104072969 cites W1994193851 @default.
• W2104072969 cites W1999563133 @default.
• W2104072969 cites W2004099033 @default.
• W2104072969 cites W2008865737 @default.
• W2104072969 cites W2009629707 @default.
• W2104072969 cites W2030528783 @default.
• W2104072969 cites W2052181632 @default.
• W2104072969 cites W2071602052 @default.
• W2104072969 cites W2078893799 @default.
• W2104072969 cites W2084414513 @default.
• W2104072969 cites W2085543001 @default.
• W2104072969 cites W2086702949 @default.
• W2104072969 cites W2098585520 @default.
• W2104072969 cites W2099361912 @default.
• W2104072969 cites W2102942095 @default.
• W2104072969 cites W2109479504 @default.
• W2104072969 cites W2136415416 @default.
• W2104072969 cites W2137077776 @default.
• W2104072969 cites W2169965478 @default.
• W2104072969 cites W2197145779 @default.
• W2104072969 cites W4256375696 @default.
• W2104072969 doi "https://doi.org/10.1158/1078-0432.ccr-14-1954" @default.
• W2104072969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25977342" @default.
• W2104072969 hasPublicationYear "2015" @default.
• W2104072969 type Work @default.
• W2104072969 sameAs 2104072969 @default.
• W2104072969 citedByCount "74" @default.
• W2104072969 countsByYear W21040729692015 @default.
• W2104072969 countsByYear W21040729692016 @default.
• W2104072969 countsByYear W21040729692017 @default.
• W2104072969 countsByYear W21040729692018 @default.
• W2104072969 countsByYear W21040729692019 @default.
• W2104072969 countsByYear W21040729692020 @default.
• W2104072969 countsByYear W21040729692021 @default.
• W2104072969 countsByYear W21040729692022 @default.
• W2104072969 countsByYear W21040729692023 @default.
• W2104072969 crossrefType "journal-article" @default.
• W2104072969 hasAuthorship W2104072969A5005962077 @default.
• W2104072969 hasAuthorship W2104072969A5015972707 @default.
• W2104072969 hasAuthorship W2104072969A5017953971 @default.
• W2104072969 hasAuthorship W2104072969A5023161976 @default.
• W2104072969 hasAuthorship W2104072969A5045902068 @default.
• W2104072969 hasAuthorship W2104072969A5073631191 @default.
• W2104072969 hasConcept C118131993 @default.
• W2104072969 hasConcept C121608353 @default.
• W2104072969 hasConcept C126322002 @default.
• W2104072969 hasConcept C143998085 @default.
• W2104072969 hasConcept C146357865 @default.
• W2104072969 hasConcept C151730666 @default.
• W2104072969 hasConcept C2777546739 @default.
• W2104072969 hasConcept C2778019345 @default.
• W2104072969 hasConcept C2778695046 @default.
• W2104072969 hasConcept C2779013556 @default.
• W2104072969 hasConcept C2779256057 @default.
• W2104072969 hasConcept C71924100 @default.
• W2104072969 hasConcept C86803240 @default.
• W2104072969 hasConcept C90924648 @default.
• W2104072969 hasConceptScore W2104072969C118131993 @default.
• W2104072969 hasConceptScore W2104072969C121608353 @default.
• W2104072969 hasConceptScore W2104072969C126322002 @default.
• W2104072969 hasConceptScore W2104072969C143998085 @default.
• W2104072969 hasConceptScore W2104072969C146357865 @default.
• W2104072969 hasConceptScore W2104072969C151730666 @default.
• W2104072969 hasConceptScore W2104072969C2777546739 @default.
• W2104072969 hasConceptScore W2104072969C2778019345 @default.
• W2104072969 hasConceptScore W2104072969C2778695046 @default.
• W2104072969 hasConceptScore W2104072969C2779013556 @default.
• W2104072969 hasConceptScore W2104072969C2779256057 @default.
• W2104072969 hasConceptScore W2104072969C71924100 @default.
• W2104072969 hasConceptScore W2104072969C86803240 @default.
• W2104072969 hasConceptScore W2104072969C90924648 @default.
• W2104072969 hasIssue "16" @default.
• W2104072969 hasLocation W21040729691 @default.
• W2104072969 hasLocation W21040729692 @default.
• W2104072969 hasOpenAccess W2104072969 @default.
• W2104072969 hasPrimaryLocation W21040729691 @default.
• W2104072969 hasRelatedWork W2084103694 @default.
• W2104072969 hasRelatedWork W2100869382 @default.
• W2104072969 hasRelatedWork W2284613379 @default.
• W2104072969 hasRelatedWork W2938267598 @default.

• next